[1]郭世杰,齐向前.直接胆红素与非瓣膜病心房颤动类型的相关性分析[J].医学信息,2021,34(08):5-7.[doi:10.3969/j.issn.1006-1959.2021.08.002]
 GUO Shi-jie,QI Xiang-qian.Correlation Analysis Between Direct Bilirubin and Types of Atrial Fibrillation in Non-valvular Disease[J].Medical Information,2021,34(08):5-7.[doi:10.3969/j.issn.1006-1959.2021.08.002]
点击复制

直接胆红素与非瓣膜病心房颤动类型的相关性分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年08期
页码:
5-7
栏目:
出版日期:
2021-04-15

文章信息/Info

Title:
Correlation Analysis Between Direct Bilirubin and Types of Atrial Fibrillation in Non-valvular Disease
文章编号:
1006-1959(2021)08-0005-03
作者:
郭世杰齐向前
(泰达国际心血管病医院内二科,天津 300457)
Author(s):
GUO Shi-jieQI Xiang-qian
(The Second Department of Internal Medicine,TEDA International Cardiovascular Hospital,Tianjin 300457,China)
关键词:
直接胆红素心房颤动左房内径
Keywords:
Direct bilirubinAtrial fibrillationLeft atrial diameter
分类号:
R541.7+1
DOI:
10.3969/j.issn.1006-1959.2021.08.002
文献标志码:
A
摘要:
目的 探讨直接胆红素与非瓣膜病心房颤动类型的相关性。方法 选取2015年1月~2019年1月在我院住院的非瓣膜病房颤患者337例,其中阵发性房颤患者234例为阵发房颤组,持续性及永久性房颤患者103例为慢性房颤组,比较两组临床资料,采用Spearman相关及二分类Logistic回归模型分析直接胆红素与房颤类型的关系。结果 慢性房颤组男性比例、体重、尿酸、总胆红素、直接胆红素、左房直径、左室舒张末内径、右房直径、右室舒张末内径高于阵发性房颤组,LVEF低于阵发性房颤组,差异有统计学意义(P<0.05);两组年龄、身高、白细胞计数、红细胞计数、血红蛋白、血小板计数、D-二聚体、肌酐、TC、TG、LDL、谷丙转氨酶、TSH、TT3、TT4、BNP、高血压史、糖尿病史、吸烟史、饮酒史比较,差异无统计学意义(P>0.05)。Spearman相关性分析显示,体重、尿酸、总胆红素、直接胆红素、左房内径、左室舒张末内径、右房内径及右室舒张末内径与慢性房颤之间呈正相关(r=0.133、0.178、0.193、0.225、0.470、0.122、0.390、0.294,P<0.05),左室射血分数与慢性房颤呈负相关(r=-0.216,P<0.05)。二分类Logistic回归模型分析显示,左房内径与慢性房颤独立相关,直接胆红素未进入回归方程。结论 直接胆红素与非瓣膜病心房颤动类型无独立相关性,心房体积增大是阵发房颤进展为慢性房颤的独立危险因素。
Abstract:
Objective To investigate the correlation between direct bilirubin and the types of non-valvular atrial fibrillation.Methods A total of 337 patients with non-valvular atrial fibrillation who were hospitalized in our hospital from January 2015 to January 2019 were selected. Among them, 234 patients with paroxysmal atrial fibrillation were included in the paroxysmal atrial fibrillation group.103 patients with persistent and permanent atrial fibrillation belong to the chronic atrial fibrillation group.The clinical data of the two groups were compared, and the Spearman correlation and binary Logistic regression model were used to analyze the relationship between direct bilirubin and the type of atrial fibrillation.Results The proportion of men in the chronic atrial fibrillation group, body weight, uric acid, total bilirubin, direct bilirubin, left atrial diameter, left ventricular end diastolic inner diameter, right atrial diameter, and right ventricular end diastolic inner diameter were higher than those in paroxysmal atrial fibrillation group. LVEF was lower than paroxysmal atrial fibrillation group, the difference was statistically significant (P<0.05);Two groups of age, height, white blood cell count, red blood cell count, hemoglobin, platelet count, D-dimer, creatinine, TC, TG, LDL, alanine aminotransferase, TSH, TT3, TT4, BNP, history of hypertension, history of diabetes, there was no statistically significant difference between smoking history and drinking history (P>0.05).Spearman correlation analysis showed that body weight, uric acid, total bilirubin, direct bilirubin, left atrial diameter, left ventricular end diastolic diameter, right atrial diameter and right ventricular end diastolic diameter were positively correlated with chronic atrial fibrillation (r=0.133, 0.178, 0.193, 0.225, 0.470, 0.122, 0.390, 0.294,P<0.05),left ventricular ejection fraction was negatively correlated with chronic atrial fibrillation (r=-0.216, P<0.05).The analysis of the binary Logistic regression model showed that the left atrial diameter was independently related to chronic atrial fibrillation, and the direct bilirubin did not enter the regression equation.Conclusion There is no independent correlation between direct bilirubin and the types of non-valvular atrial fibrillation. Increased atrial volume is an independent risk factor for the progression of paroxysmal atrial fibrillation to chronic atrial fibrillation.

参考文献/References:

[1]Samman TA,Sandesara PB,Hayek SS,et al.Association between oxidative stress and atrial fibrillation[J].Heart Rhythm,2017,14(12):1849-1855. [2]Cho HS,Lee SW,Kim ES,et al.Serum bilirubin levels are inversely associated with PA-1 and fibrinogen in Korean subjects[J].Atherosclerosis,2016,1(244):204-210. [3]繆帅,刘彤,李美佳,等.高血压患者红细胞分布宽度及直接胆红素与心房颤动的关系[J].天津医药,2013,41(6):593-595. [4]Chen SC,Chung FP,Chao TF,et al.A link between bilirubin levels and atrial fibrillation recurrence after catheter ablation[J].J Chin Med Assoc,2019,82(3):175-178. [5]Lau DH,Linz D,Sanders P.New Findings in Atrial Fibrillation Mechanisms[J].Card Electrophysiol Clin,2019,11(4):563-571. [6]高秀荣,吉宗珊,孙丽君,等.左房内径、血清尿酸水平与老年心房颤动的相关性分析[J].现代生物医学进展,2017,17(11):2148-2151.

相似文献/References:

[1]姜亦瑶,王 凯,施 超.心肌纤维化引发心房颤动的研究进展[J].医学信息,2018,31(12):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
 JIANG Yi-yao,WANG Kai,SHI Chao.Research Progress of Atrial Fibrillation Caused by Myocardial Fibrosis[J].Medical Information,2018,31(08):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
[2]张定欣,林先和.经食道三维超声在房颤二尖瓣结构变化对其 返流程度影响中的应用[J].医学信息,2018,31(12):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
 ZHANG Ding-xin,LIN Xian-he.Application of Transesophageal Three-dimensional Ultrasound in the Influence of Mitral Valve Structure Changes on the Degree of Reflux in Atrial Fibrillation[J].Medical Information,2018,31(08):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
[3]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对 糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
 WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Medical Information,2018,31(08):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[4]陶春艳.柔性护理在胺碘酮治疗心房颤动护理中的应用研究[J].医学信息,2018,31(24):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
 TAO Chun-yan.Application of Flexible Nursing in the Treatment of Atrial Fibrillation with Amiodarone[J].Medical Information,2018,31(08):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
[5]古俊楠,张牧秋,王建强,等.可穿戴设备在心房颤动诊治中的应用[J].医学信息,2019,32(15):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
 GU Jun-nan,ZHANG Mu-qiu,WANG Jian-qiang,et al.Application of Wearable Devices in the Diagnosis and Treatment of Atrial Fibrillation[J].Medical Information,2019,32(08):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
[6]刘 瑜,王建强,古俊楠,等.房颤合并功能性二尖瓣返流研究[J].医学信息,2019,32(15):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
 LIU Yu,WANG Jian-qiang,GU Jun-nan,et al.Study on Atrial Fibrillation Combined with Functional Mitral Regurgitation[J].Medical Information,2019,32(08):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
[7]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
 ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Medical Information,2019,32(08):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[8]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
 WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and ACS[J].Medical Information,2019,32(08):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[9]朱文书,张理想,游杨杨,等.长链非编码RNA MIAT表达水平与心房颤动导管消融术后复发的关系[J].医学信息,2021,34(04):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
 ZHU Wen-shu,ZHANG Li-xiang,YOU Yang-yang,et al.Relationship Between the Expression Level of Long Non-coding RNA MIAT and Recurrence After Catheter Ablation of Atrial Fibrillation[J].Medical Information,2021,34(08):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
[10]马 利,李丽华.aVR导联法在心房颤动伴宽QRS波群心动过速鉴别诊断中的应用[J].医学信息,2022,35(19):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
 MA Li,LI Li-hua.Application of aVR Lead Method in Differential Diagnosis of Atrial Fibrillation with Wide QRS Complex Tachycardia[J].Medical Information,2022,35(08):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]

更新日期/Last Update: 1900-01-01